Solutions for Life Science & Diagnostics

MBL International Corporation is a leading life science company focused on providing high-quality products and solutions for life science research and clinical diagnostics.

Established in 1993 as a subsidiary of Medical and Biological Laboratories Co. Ltd, Nagoya, Japan, MBL International Corporation develops, manufactures and markets a wide range of ELISA and IFA test kits to aid in the diagnosis of autoimmune and infectious disease as well as an extensive portfolio of monoclonal and polyclonal antibodies, fluorescent and recombinant proteins, and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience.

Our products are used widely in academic research institutions, pharmaceutical and biotechnology companies, government agencies, as well as hospital and reference laboratories. By providing a consultative approach, superior technical and customer support, and convenient purchasing options, MBL International Corporation partners with our customers to solve their scientific and clinical challenges. Learn More »

Recent Brochures and Application Notes


The BRIC Kit provides researchers with reproducible and accurate results for monitoring RNA half-life and stability in living cells.

Anti-p53 ELISA Kit

ELISA test for the detection of tumor-associated autoantibodies (anti-p53 antibodies)

Product Citations

Special Promotions

$100 Off on Over 1100 Antibodies


June 12, 2014
MBL International Corporation opens a new R&D laboratory

newMBL International Corporation opens a new R&D laboratory
MBL International Corporation (MBLI), headquartered in Woburn, MA, USA, a wholly owned company of Medical & Biological Laboratories, Co., Ltd. in Japan in collaboration with SCIVAX USA, has announced opening a new R&D laboratory.

Upcoming Events

ACR Annual Meeting

The ACR/ARHP Annual Meeting brings together nearly 15,000 domestic and international participants, including physicians, health professionals, and industry partners from over 100 countries.

This six day meeting will showcase cutting edge and timely topics in clinical and basic science of rheumatologic care, as well as the prevention, diagnosis, and treatment of rheumatic diseases and its comorbid conditions.

Attendees will be able to choose from over 200 educational presentations, which will be delivered using various skills-based, interactive learning formats designed to maximize the attendees’ learning experience. Workshops, Meet the Professors, oral abstract sessions, poster presentations and guided poster tours are only some of the exciting offerings that will be available to all attendees.


Neuroscience 2014

SfN's 44th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.